Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01188863 · ClinicalTrials.gov registry record · Phase 1

Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus

A Phase 1 study of Type 2 Diabetes Mellitus, sponsored by Lexicon Pharmaceuticals.

Completed
Registry status
Phase 1
Development phase
15
Enrollment target
1
Study location

NCT01188863 is a Phase 1 study of Type 2 Diabetes Mellitus that has completed, run by Lexicon Pharmaceuticals. The registered enrollment target is 15 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01188863, a Phase 1 study of Type 2 Diabetes Mellitus, has completed, sponsored by Lexicon Pharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This protocol is intended to compare the effects of both a solid (tablet) and liquid oral dosage form of LX4211 in subjects with type 2 diabetes mellitus.

Conditions Studied

Type 2 Diabetes Mellitus

Interventions

  • DRUG 300 mg LX4211 (150 mg tablets)
  • DRUG 300 mg LX4211 (50 mg tablets)
  • DRUG 300 mg LX4211 (liquid)

Study Locations (1)

Texas

  • Lexicon Investigational Site - San Antonio

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2010-09
Phase Phase 1

Sponsor

Lexicon Pharmaceuticals

56 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01188863

The ClinicalTrials.gov registry entry for NCT01188863 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Lexicon Pharmaceuticals, which has 56 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which 300 mg LX4211 (150 mg tablets) is the first listed.

NCT01188863 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01188863 about?

NCT01188863 is a clinical study titled "Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus". This protocol is intended to compare the effects of both a solid (tablet) and liquid oral dosage form of LX4211 in subjects with type 2 diabetes mellitus.

What is the current status of trial NCT01188863?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2010-09.

What conditions does trial NCT01188863 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT01188863?

The interventions under investigation include: 300 mg LX4211 (150 mg tablets) (DRUG), 300 mg LX4211 (50 mg tablets) (DRUG), 300 mg LX4211 (liquid) (DRUG).

Who is sponsoring clinical trial NCT01188863?

This trial is sponsored by Lexicon Pharmaceuticals, which has 56 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01188863 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes Mellitus

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.